Norbert G. Riedel, Ph.D.

Norbert G. Riedel, Ph.D.

INDEPENDENT DIRECTORatJazz Pharmaceuticals· In proxies 2023–2025

Norbert G. Riedel, Ph.D. sits on 11 public boards.

Boards2

  • Eton PharmaceuticalsChair · 8 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance (Chair)—Paid as an executive
  • Jazz PharmaceuticalsDirector · 10 yr on the boardIndependentCompensation and Management Development, Science and Medicine (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Jazz PharmaceuticalsPublic company · 3 yr
    • INDEPENDENT DIRECTOR2023 – Present · 3 yrStock in role +29%
  2. Eton PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  3. Eton Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Illinois Biotechnology Innovation OrganizationPublic company
    • Director? – PresentNo stock prices for these years
  5. Jazz Pharmaceuticals, Cerevel TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  6. Genome Therapeutics CorporationPublic company
    • Director? – PresentNo stock prices for these years
  7. Oscient Pharmaceuticals CorporationPublic company
    • Director? – PresentNo stock prices for these years
  8. Cerevel Therapeutics Holdings, Inc.Public company · 4 yr
    • Director2020 – 2024 · 4 yrNo stock prices for these years
  9. Ariad Pharmaceuticals, Inc.Public company · 6 yr
    • Director2011 – 2017 · 6 yrNo stock prices for these years
  10. MediGene AGPublic company · 10 yr
    • Director2003 – 2013 · 10 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?